DS
DSCI

David Shaw’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

David Shaw’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-49,791
Closed -$259K – 3833
2016
Q4 		$259K Sell
49,791
-42,523
-46% -$200K ﹤0.01% 3170
2016
Q3 		$431K Sell
92,314
-227,005
-71% -$1.06M ﹤0.01% 2870
2016
Q2 		$1.26M Sell
319,319
-5,394
-2% -$20.2K ﹤0.01% 2264
2016
Q1 		$1.01M Buy
324,713
+23,591
+8% +$79K ﹤0.01% 2349
2015
Q4 		$1.38M Buy
301,122
+100,862
+50% +$478K ﹤0.01% 2427
2015
Q3 		$943K Buy
200,260
+47,088
+31% +$304K ﹤0.01% 2638
2015
Q2 		$1.1M Buy
153,172
+90,866
+146% +$683K ﹤0.01% 2639
2015
Q1 		$528K Buy
62,306
+23,809
+62% +$203K ﹤0.01% 3023
2014
Q4 		$358K Buy
+38,497
New +$335K ﹤0.01% 3548
2014
Q2 		– Sell
-11,223
Closed -$142K – 4911
2014
Q1 		$142K Buy
11,223
+172
+2% +$2.22K ﹤0.01% 4142
2013
Q4 		$120K Buy
+11,051
New +$128K ﹤0.01% 4351

Other funds holding DSCI

FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return

David Shaw's DSCI Position: Q1 2017 in Review

David Shaw sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 49,791 shares — an estimated $259K sold.

David Shaw first reported a position in DSCI in Q4 2013 and held it in 11 quarters. The position peaked at $1.38M in Q4 2015. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • David Shaw reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • David Shaw sold 49,791 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $259K.
  • David Shaw first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2013 and held it in 11 quarters.
  • David Shaw's Derma Sciences, Inc. Common Stock (DE) position peaked at $1.38M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.